Subject(s)
Organ Transplantation , Humans , United States/epidemiology , Female , Organ Transplantation/adverse effects , Organ Transplantation/statistics & numerical data , Male , Middle Aged , Adult , Aged , Transplant Recipients/statistics & numerical data , Genital Neoplasms, Female/epidemiology , Genital Neoplasms, Male/epidemiology , Cohort Studies , Risk Assessment/statistics & numerical data , Incidence , Risk FactorsABSTRACT
Purpose: We report a novel case of a transgender woman who experienced excess mucosal secretion leading to symptomatic skin irritation after her colonic vaginoplasty successfully treated with glycopyrrolate. Methods: This is a case report of a 47-year-old transgender woman with symptomatic excess mucosal secretion and skin irritation from colonic vaginoplasty, and we describe her treatment course and responses. Patient consent was obtained for publication. Results: The patient's chronic neovaginal discharge improved with glycopyrrolate. Conclusions: Anticholinergic drugs may be helpful in treating patients who experience chronic neovaginal discharge following colonic vaginoplasty.
ABSTRACT
This cross-sectional study examines racial and ethnic diversity trends among dermatology resident trainees and applicants compared with other specialties.
Subject(s)
Dermatology , Humans , Ethnicity , Hispanic or LatinoABSTRACT
The human immunodeficiency virus (HIV) pandemic has disproportionately affected tropical regions of the world, where dermatoses, such as leprosy and leishmaniasis, rarely encountered in temperate climates, are endemic. Although the introduction of highly active antiretroviral therapy (HAART) has been lifesaving, a few patients undergoing HAART experience clinical deterioration caused by immune reconstitution inflammatory syndrome (IRIS). This article explores the range of tropical dermatoses that are reported to date with associated IRIS events.
Subject(s)
Antiretroviral Therapy, Highly Active/adverse effects , HIV Infections/complications , Immune Reconstitution Inflammatory Syndrome/complications , Skin Diseases/complications , Skin Diseases/immunology , Humans , Leishmaniasis/complications , Leishmaniasis/immunology , Leprosy/complications , Leprosy/immunology , Mycoses/microbiology , Penicillium , Sporotrichosis/complications , Sporotrichosis/immunology , Strongyloidiasis/complications , Tropical ClimateABSTRACT
Dermatologic disease is common in HIV-infected individuals, and clinicians caring for patients with HIV infection or AIDS in Africa are routinely confronted with skin problems in their patients. Scarce access to dermatologic specialty care and limited educational resources describing the unique clinical characteristics of HIV-related skin disease can make diagnosing and treating skin diseases a challenge in Africa. This article describes common HIV-related dermatologic conditions in Africa and their differential diagnoses and includes treatment strategies that are likely to be available locally. It is not meant to be comprehensive but rather to serve as a practical resource to aid practitioners by providing images of common conditions and describing distinctive clinical presentations of common conditions.